Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Implementation of exome sequencing for rare undiagnosed diseases in LMICs: the G2MC rare diseases exome sequencing pilot project

Yasas D. Kolambage C. Gonzaga-Jauregui Guillermo Lay-Son Rupesh Mishra N. Mabaso S. Tae Kristin A. Maloney C. Galaz-Montoya Dineshani Hettiarachchi B. Dillon Nilam Thakur L. de Menten Cecilia Mellado C. Greene Toni I. Pollin A. Krause M. Thong A. Shuldiner V. Dissanayake
Jul 2026 · Human Genetics · Vol 145 · 0 citations · 26 references
Medicine

TL;DR

The feasibility, effectiveness, and adaptability of implementing exome sequencing in resource-limited settings are demonstrated and its potential to transform rare disease diagnosis and care in low- and middle-income countries is highlighted.

DOI PubMed Semantic Scholar
View source

Similar papers

Open access Sep 2026

Genomic Research as a Critical Pathway to Diagnosis for Individuals with Rare Disease

RGP demonstrates that a research-based, patient-driven remote sequencing study can effectively bridge a diagnostic gap for rare disease families underserved in current clinical care and underscores the clinical utility of GS with frequent re-analysis.

A. O'Donnell-Luria, S. DiTroia, Melanie C. O'Leary et al. · 0 citations
Review Open access Aug 2026

Detecting pathogenic structural variation in families with undiagnosed rare disease in a national genome project.

It is demonstrated that LRS-based SV analysis, supported by orthogonal SRS re-analysis, can resolve clinically significant SVs in families who remain unsolved after standard rare disease testing.

P. Dutta, A. Pagnamenta, Christelle Robert et al. · 0 citations
Open access Jan 2026

Whole‐Exome Sequencing in Undiagnosed Muscular Dystrophies: A High Diagnostic Yield and Novel Insights From Iranian Families

This study expands the mutational spectrum of MDs in Iran and provides critical data for genetic counseling, prenatal diagnosis, and future therapeutic development, and underscores the importance of population‐specific genomic studies.

Nasibeh Soltani, Zahra Shahbazi, M. Fallah et al. · 0 citations
Open access Sep 2026

Proteomics identify disease-associated variants in patients with rare diseases undiagnosed after genome sequencing.

Despite the introduction of genome sequencing (GS) for rare disease diagnostics, a genetic cause is not identified in most patients. Here, we explored the potential of proteomics to improve the diagnostic yield in 424 patients with rare diseases from the 100,000 Genomes Project (100kGP) without a genetic diagnosis. Ser...

J. Carrasco-Zanini, J. Andrade, M. Pietzner et al. · 0 citations
Open access Aug 2026

Whole-exome sequencing reveals the genetic landscape and polygenic susceptibility in 1241 patients with clinically suspected hemophagocytic lymphohistiocytosis

Hemophagocytic lymphohistiocytosis (HLH) is a severe immunological disorder characterized by dysregulated immune activation. Pathogenic variants in HLH-causative genes serve as diagnostic criteria and guide treatment decisions. However, known genes do not fully explain the molecular basis of many cases, and the pol...

Yu-Huan Meng, Mao-Ting Shen, Shu-yi Guo et al. · 0 citations
Open access Sep 2026

Genome sequencing improves diagnostic outcomes over panel and exome sequencings in myopathies: findings from the French PFMG2025 initiative

Genome Sequencing showed GS as a valuable and feasible approach allowing the elucidation of complex variants and the discovery of new pathogenic mechanisms in the context of myopathy, as part of a large national scale GS strategy piloted by the French Genomic Medicine Initiative.

Camille Verebi, A. Maino, C. Métay et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.